DKCM
CERE

Davidson Kempner Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Davidson Kempner Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-260,399
Closed -$10.6M – 300
2024
Q2 		$10.6M Buy
+260,399
New +$10.8M 0.17% 118

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Davidson Kempner Capital Management's CERE Position: Q3 2024 in Review

Davidson Kempner Capital Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 260,399 shares — an estimated $10.6M sold.

Davidson Kempner Capital Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $10.6M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Davidson Kempner Capital Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 260,399 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $10.6M.
  • Davidson Kempner Capital Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $10.6M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.